RT Book, Section
A1 Wright, Chanin C.
A1 Vera, Yolanda
A2 DiPiro, Joseph T.
A2 Yee, Gary C.
A2 Posey, L. Michael
A2 Haines, Stuart T.
A2 Nolin, Thomas D.
A2 Ellingrod, Vicki
SR Print(0)
ID 1182435770
T1 Cystic Fibrosis
T2 Pharmacotherapy: A Pathophysiologic Approach, 11e
YR 2020
FD 2020
PB McGraw-Hill Education
PP New York, NY
SN 9781260116816
LK accesspharmacy.mhmedical.com/content.aspx?aid=1182435770
RD 2024/04/25
AB KEY  CONCEPTS  Good  nutrition  with  appropriate  pancreatic  enzyme  and  vitamin  supplementation  are  essential  in  the  management  of  cystic  fibrosis  (CF).  Airway  clearance  and  anti-inflammatory  therapies  are  key  components  to  improve  pulmonary  health  in  CF  patients.  Antipseudomonal  agents  are  the  cornerstone  of  antibiotic  therapy  for  chronic  lung  infections  in  the  CF  patient.  Altered  pharmacokinetics  of  CF  patients  can  impact  the  dosing  and  clearance  of  pharmacologic  therapy.